Saliva for molecular detection of SARS‐CoV‐2 in pre‐school and school‐age children

SARS‐CoV‐2 diagnosis is a cornerstone for the management of coronavirus disease 2019 (COVID‐19). Numerous studies have assessed saliva performance over nasopharyngeal sampling (NPS), but data in young children are still rare. We explored saliva performance for SARS‐CoV‐2 detection by RT‐PCR accordin...

Full description

Saved in:
Bibliographic Details
Published inEnvironmental microbiology Vol. 24; no. 10; pp. 4725 - 4737
Main Authors Delaunay‐Moisan, Agnes, Guilleminot, Tiffany, Semeraro, Michaela, Briand, Nelly, Bader‐Meunier, Brigitte, Berthaud, Romain, Morelle, Guillaume, Quartier, Pierre, Galeotti, Caroline, Basmaci, Romain, Benoist, Gregoire, Gajdos, Vincent, Lorrot, Mathie, Rifai, Mahmoud, Crespin, Matis, M'Sakni, Zakary, Padavia, Faheemah, Savetier‐Leroy, Catherine, Lorenzi, Michelle, Maurin, Caroline, Behillil, Sylvie, Pontual, Loic, Elenga, Narcisse, Bouazza, Naim, Moltrecht, Brigitte, Werf, Sylvie, Leruez‐Ville, Marianne, Sermet‐Gaudelus, Isabelle
Format Journal Article
LanguageEnglish
Published Hoboken, USA John Wiley & Sons, Inc 01.10.2022
Wiley Subscription Services, Inc
Society for Applied Microbiology and Wiley-Blackwell
SeriesThematic Issue on Pathogen and Antimicrobial Resistance Ecology
Subjects
Online AccessGet full text

Cover

Loading…
Abstract SARS‐CoV‐2 diagnosis is a cornerstone for the management of coronavirus disease 2019 (COVID‐19). Numerous studies have assessed saliva performance over nasopharyngeal sampling (NPS), but data in young children are still rare. We explored saliva performance for SARS‐CoV‐2 detection by RT‐PCR according to the time interval from initial symptoms or patient serological status. We collected 509 NPS and saliva paired samples at initial diagnosis from 166 children under 12 years of age (including 57 children under 6), 106 between 12 and 17, and 237 adults. In children under 12, overall detection rate for SARS‐CoV‐2 was comparable in saliva and NPS, with an overall agreement of 89.8%. Saliva sensitivity was significantly lower than that of NPS (77.1% compared to 95.8%) in pre‐school and school‐age children but regained 96% when considering seronegative children only. This pattern was also observed to a lesser degree in adolescents but not in adults. Sensitivity of saliva was independent of symptoms, in contrary to NPS, whose sensitivity decreased significantly in asymptomatic subjects. Performance of saliva is excellent in children under 12 at early stages of infection. This reinforces saliva as a collection method for early and unbiased SARS‐CoV‐2 detection and a less invasive alternative for young children.
AbstractList SARS‐CoV‐2 diagnosis is a cornerstone for the management of coronavirus disease 2019 (COVID‐19). Numerous studies have assessed saliva performance over nasopharyngeal sampling (NPS), but data in young children are still rare. We explored saliva performance for SARS‐CoV‐2 detection by RT‐PCR according to the time interval from initial symptoms or patient serological status. We collected 509 NPS and saliva paired samples at initial diagnosis from 166 children under 12 years of age (including 57 children under 6), 106 between 12 and 17, and 237 adults. In children under 12, overall detection rate for SARS‐CoV‐2 was comparable in saliva and NPS, with an overall agreement of 89.8%. Saliva sensitivity was significantly lower than that of NPS (77.1% compared to 95.8%) in pre‐school and school‐age children but regained 96% when considering seronegative children only. This pattern was also observed to a lesser degree in adolescents but not in adults. Sensitivity of saliva was independent of symptoms, in contrary to NPS, whose sensitivity decreased significantly in asymptomatic subjects. Performance of saliva is excellent in children under 12 at early stages of infection. This reinforces saliva as a collection method for early and unbiased SARS‐CoV‐2 detection and a less invasive alternative for young children.
SARS-CoV-2 diagnosis is a cornerstone for the management of coronavirus disease 2019 (COVID-19). Numerous studies have assessed saliva performance over nasopharyngeal sampling (NPS), but data in young children are still rare. We explored saliva performance for SARS-CoV-2 detection by RT-PCR according to the time interval from initial symptoms or patient serological status. We collected 509 NPS and saliva paired samples at initial diagnosis from 166 children under 12 years of age (including 57 children under 6), 106 between 12 and 17, and 237 adults. In children under 12, overall detection rate for SARS-CoV-2 was comparable in saliva and NPS, with an overall agreement of 89.8%. Saliva sensitivity was significantly lower than that of NPS (77.1% compared to 95.8%) in pre-school and school-age children but regained 96% when considering seronegative children only. This pattern was also observed to a lesser degree in adolescents but not in adults. Sensitivity of saliva was independent of symptoms, in contrary to NPS, whose sensitivity decreased significantly in asymptomatic subjects. Performance of saliva is excellent in children under 12 at early stages of infection. This reinforces saliva as a collection method for early and unbiased SARS-CoV-2 detection and a less invasive alternative for young children.SARS-CoV-2 diagnosis is a cornerstone for the management of coronavirus disease 2019 (COVID-19). Numerous studies have assessed saliva performance over nasopharyngeal sampling (NPS), but data in young children are still rare. We explored saliva performance for SARS-CoV-2 detection by RT-PCR according to the time interval from initial symptoms or patient serological status. We collected 509 NPS and saliva paired samples at initial diagnosis from 166 children under 12 years of age (including 57 children under 6), 106 between 12 and 17, and 237 adults. In children under 12, overall detection rate for SARS-CoV-2 was comparable in saliva and NPS, with an overall agreement of 89.8%. Saliva sensitivity was significantly lower than that of NPS (77.1% compared to 95.8%) in pre-school and school-age children but regained 96% when considering seronegative children only. This pattern was also observed to a lesser degree in adolescents but not in adults. Sensitivity of saliva was independent of symptoms, in contrary to NPS, whose sensitivity decreased significantly in asymptomatic subjects. Performance of saliva is excellent in children under 12 at early stages of infection. This reinforces saliva as a collection method for early and unbiased SARS-CoV-2 detection and a less invasive alternative for young children.
Author Benoist, Gregoire
Quartier, Pierre
Galeotti, Caroline
Delaunay‐Moisan, Agnes
Rifai, Mahmoud
Basmaci, Romain
Werf, Sylvie
Moltrecht, Brigitte
Gajdos, Vincent
Behillil, Sylvie
Berthaud, Romain
Maurin, Caroline
Morelle, Guillaume
Savetier‐Leroy, Catherine
Briand, Nelly
Lorrot, Mathie
Lorenzi, Michelle
Sermet‐Gaudelus, Isabelle
Leruez‐Ville, Marianne
Guilleminot, Tiffany
Padavia, Faheemah
M'Sakni, Zakary
Pontual, Loic
Bader‐Meunier, Brigitte
Semeraro, Michaela
Elenga, Narcisse
Crespin, Matis
Bouazza, Naim
AuthorAffiliation 13 Centre de Référence des Virus émergents. Institut Pasteur France
14 Service de Pédiatrie Générale Hôpital Jean Verdier, Assistance Publique Hôpitaux de Paris, Université Sorbonne Paris Nord France
1 Université Paris‐Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC) Gif‐sur‐Yvette France
7 Service de Pédiatrie Générale, Hôpital Louis Mourier Assistance Publique Hôpitaux de Paris France
11 Centre de Références Maladies Rares Mucoviscidose et Maladies Apparentées CHU Necker Enfants Malades, Assistance Publique Hôpitaux de Paris Paris 75015 France
9 Service de Pédiatrie Générale Hôpital Antoine Beclère, Assistance Publique Hôpitaux de Paris France
10 Service de Pédiatrie Générale Hôpital Armand Trousseau, Assistance Publique Hôpitaux de Paris France
5 Reference centre for Rheumatic, AutoImmune and Systemic Diseases in Children (RAISE), Imagine Institute,Inserm U 1163 Paris France
15 Service de Pédiatrie Générale Centre Hospitalier de Cayenne Andrée Rosemon France
3 Unité de
AuthorAffiliation_xml – name: 4 Department of Paediatric Hematology‐Immunology and Rheumatology Necker‐Enfants Malades Hospital, AP‐HP Paris France
– name: 12 Ministère de l'Education Nationale Médecine Scolaire France
– name: 7 Service de Pédiatrie Générale, Hôpital Louis Mourier Assistance Publique Hôpitaux de Paris France
– name: 15 Service de Pédiatrie Générale Centre Hospitalier de Cayenne Andrée Rosemon France
– name: 9 Service de Pédiatrie Générale Hôpital Antoine Beclère, Assistance Publique Hôpitaux de Paris France
– name: 1 Université Paris‐Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC) Gif‐sur‐Yvette France
– name: 14 Service de Pédiatrie Générale Hôpital Jean Verdier, Assistance Publique Hôpitaux de Paris, Université Sorbonne Paris Nord France
– name: 3 Unité de Recherche Clinique‐Centre Investigation Clinique, Hôpital Necker‐Enfants Malades, Assistance Publique Hôpitaux de Paris France
– name: 10 Service de Pédiatrie Générale Hôpital Armand Trousseau, Assistance Publique Hôpitaux de Paris France
– name: 13 Centre de Référence des Virus émergents. Institut Pasteur France
– name: 6 Service de Pédiatrie Générale, Hôpital Kremlin Bicêtre Assistance Publique Hôpitaux de Paris France
– name: 2 Virology Laboratory Hospital Necker‐Enfants‐Malades, Assistance Publique Hôpitaux de Paris UMR 7328 Imagine Paris Cité Paris France
– name: 5 Reference centre for Rheumatic, AutoImmune and Systemic Diseases in Children (RAISE), Imagine Institute,Inserm U 1163 Paris France
– name: 17 European Reference Network for Rare Respiratory Diseases Belgium
– name: 16 Institut Necker Enfants Malades, INSERM UMR‐SU1151, Université Paris Cité France
– name: 8 Service de Pédiatrie Générale Hôpital Ambroise Paré, Assistance Publique Hôpitaux de Paris France
– name: 11 Centre de Références Maladies Rares Mucoviscidose et Maladies Apparentées CHU Necker Enfants Malades, Assistance Publique Hôpitaux de Paris Paris 75015 France
Author_xml – sequence: 1
  givenname: Agnes
  orcidid: 0000-0003-3105-221X
  surname: Delaunay‐Moisan
  fullname: Delaunay‐Moisan, Agnes
  email: agnes.delaunay-moisan@cea.fr
  organization: Université Paris‐Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC)
– sequence: 2
  givenname: Tiffany
  surname: Guilleminot
  fullname: Guilleminot, Tiffany
  organization: Hospital Necker‐Enfants‐Malades, Assistance Publique Hôpitaux de Paris UMR 7328 Imagine Paris Cité
– sequence: 3
  givenname: Michaela
  surname: Semeraro
  fullname: Semeraro, Michaela
  organization: Unité de Recherche Clinique‐Centre Investigation Clinique, Hôpital Necker‐Enfants Malades, Assistance Publique Hôpitaux de Paris
– sequence: 4
  givenname: Nelly
  surname: Briand
  fullname: Briand, Nelly
  organization: Unité de Recherche Clinique‐Centre Investigation Clinique, Hôpital Necker‐Enfants Malades, Assistance Publique Hôpitaux de Paris
– sequence: 5
  givenname: Brigitte
  surname: Bader‐Meunier
  fullname: Bader‐Meunier, Brigitte
  organization: Reference centre for Rheumatic, AutoImmune and Systemic Diseases in Children (RAISE), Imagine Institute,Inserm U 1163
– sequence: 6
  givenname: Romain
  surname: Berthaud
  fullname: Berthaud, Romain
  organization: Unité de Recherche Clinique‐Centre Investigation Clinique, Hôpital Necker‐Enfants Malades, Assistance Publique Hôpitaux de Paris
– sequence: 7
  givenname: Guillaume
  surname: Morelle
  fullname: Morelle, Guillaume
  organization: Assistance Publique Hôpitaux de Paris
– sequence: 8
  givenname: Pierre
  surname: Quartier
  fullname: Quartier, Pierre
  organization: Necker‐Enfants Malades Hospital, AP‐HP
– sequence: 9
  givenname: Caroline
  surname: Galeotti
  fullname: Galeotti, Caroline
  organization: Assistance Publique Hôpitaux de Paris
– sequence: 10
  givenname: Romain
  surname: Basmaci
  fullname: Basmaci, Romain
  organization: Assistance Publique Hôpitaux de Paris
– sequence: 11
  givenname: Gregoire
  surname: Benoist
  fullname: Benoist, Gregoire
  organization: Hôpital Ambroise Paré, Assistance Publique Hôpitaux de Paris
– sequence: 12
  givenname: Vincent
  surname: Gajdos
  fullname: Gajdos, Vincent
  organization: Hôpital Antoine Beclère, Assistance Publique Hôpitaux de Paris
– sequence: 13
  givenname: Mathie
  surname: Lorrot
  fullname: Lorrot, Mathie
  organization: Hôpital Armand Trousseau, Assistance Publique Hôpitaux de Paris
– sequence: 14
  givenname: Mahmoud
  surname: Rifai
  fullname: Rifai, Mahmoud
  organization: CHU Necker Enfants Malades, Assistance Publique Hôpitaux de Paris
– sequence: 15
  givenname: Matis
  surname: Crespin
  fullname: Crespin, Matis
  organization: CHU Necker Enfants Malades, Assistance Publique Hôpitaux de Paris
– sequence: 16
  givenname: Zakary
  surname: M'Sakni
  fullname: M'Sakni, Zakary
  organization: CHU Necker Enfants Malades, Assistance Publique Hôpitaux de Paris
– sequence: 17
  givenname: Faheemah
  surname: Padavia
  fullname: Padavia, Faheemah
  organization: Unité de Recherche Clinique‐Centre Investigation Clinique, Hôpital Necker‐Enfants Malades, Assistance Publique Hôpitaux de Paris
– sequence: 18
  givenname: Catherine
  surname: Savetier‐Leroy
  fullname: Savetier‐Leroy, Catherine
  organization: Médecine Scolaire
– sequence: 19
  givenname: Michelle
  surname: Lorenzi
  fullname: Lorenzi, Michelle
  organization: Médecine Scolaire
– sequence: 20
  givenname: Caroline
  surname: Maurin
  fullname: Maurin, Caroline
  organization: Médecine Scolaire
– sequence: 21
  givenname: Sylvie
  surname: Behillil
  fullname: Behillil, Sylvie
  organization: Centre de Référence des Virus émergents. Institut Pasteur
– sequence: 22
  givenname: Loic
  surname: Pontual
  fullname: Pontual, Loic
  organization: Hôpital Jean Verdier, Assistance Publique Hôpitaux de Paris, Université Sorbonne Paris Nord
– sequence: 23
  givenname: Narcisse
  surname: Elenga
  fullname: Elenga, Narcisse
  organization: Centre Hospitalier de Cayenne Andrée Rosemon
– sequence: 24
  givenname: Naim
  surname: Bouazza
  fullname: Bouazza, Naim
  organization: Unité de Recherche Clinique‐Centre Investigation Clinique, Hôpital Necker‐Enfants Malades, Assistance Publique Hôpitaux de Paris
– sequence: 25
  givenname: Brigitte
  surname: Moltrecht
  fullname: Moltrecht, Brigitte
  organization: Médecine Scolaire
– sequence: 26
  givenname: Sylvie
  surname: Werf
  fullname: Werf, Sylvie
  organization: Centre de Référence des Virus émergents. Institut Pasteur
– sequence: 27
  givenname: Marianne
  surname: Leruez‐Ville
  fullname: Leruez‐Ville, Marianne
  organization: Hospital Necker‐Enfants‐Malades, Assistance Publique Hôpitaux de Paris UMR 7328 Imagine Paris Cité
– sequence: 28
  givenname: Isabelle
  surname: Sermet‐Gaudelus
  fullname: Sermet‐Gaudelus, Isabelle
  email: isabelle.sermet@aphp.fr
  organization: European Reference Network for Rare Respiratory Diseases
BackLink https://pasteur.hal.science/pasteur-04097919$$DView record in HAL
BookMark eNqFUs1uEzEQtlAr-gNnrpa4cAn1z9peX5CiqKWVgpAIcOBieb3expVjB3s3qDcegWfkSfCyVaTmElsaj2e-b2Y0MxfgJMRgAXiD0XtczhWuOJkRScqXY4ZfgPO95WSvY3IGLnJ-QAgLKtBLcEY54kxKeg5-rLR3Ow27mOAmemsGrxNsbW9N72KAsYOr-ZfV399_FvF7kQS6ALfJFjWbdYwe6tDCSS02fW-hWTvfJhtegdNO-2xfP72X4NvN9dfF7Wz5-ePdYr6cGVZKntWo5i1FHaWcECFEV64hFS3SSiqaSteG45YYU0nKW2loh5qWC9I0uqZ1TS_Bhynudmg2tjU29El7tU1uo9Ojitqp557g1uo-7pRktGaYlgCzKcD6gHY7X6qtzr0dkkIVkkJiucMF_-4pYYo_B5t7tXHZWO91sHHIitQYS4EwQsehAiPJJWMj9O0B9CEOKZTOFRRhjCImeEFdTSiTYs7JdvuCMVLjSqhx6GpcAPV_JQqDHTCM6_U43NIM54_zfjlvH4-lUdef7ibePyD6yts
CitedBy_id crossref_primary_10_1007_s11033_023_08844_0
crossref_primary_10_3390_tropicalmed9110270
Cites_doi 10.1097/INF.0000000000003198
10.3201/eid2704.204199
10.1128/JCM.02881-20
10.1097/PAS.0000000000001825
10.1093/cid/ciaa149
10.1038/s41586-021-04345-x
10.1126/science.abm4915
10.1111/odi.13934
10.1126/science.abi5273
10.1016/j.idc.2021.11.002
10.1016/j.cmi.2021.02.009
10.5694/mja2.51188
10.7326/M20-6569
10.1016/S1473-3099(21)00146-8
10.1371/journal.pone.0253007
10.1002/path.5679
10.3390/v14020313
10.1016/j.phrs.2020.105380
10.3389/fpubh.2021.589564
10.1038/s41590-021-01089-8
10.1038/s41579-020-00459-7
10.24875/BMHIM.20000204
10.1016/j.oooo.2021.01.028
10.1111/ipd.12885
10.1038/s41598-021-82787-z
10.1128/JCM.02686-20
10.1016/j.jinf.2020.06.059
10.1093/jpids/piab058
10.7554/eLife.69302
ContentType Journal Article
Copyright 2022 The Authors. published by Society for Applied Microbiology and John Wiley & Sons Ltd.
2022. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2022 The Authors. Environmental Microbiology published by Society for Applied Microbiology and John Wiley & Sons Ltd.
Attribution - NonCommercial - ShareAlike
Copyright_xml – notice: 2022 The Authors. published by Society for Applied Microbiology and John Wiley & Sons Ltd.
– notice: 2022. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2022 The Authors. Environmental Microbiology published by Society for Applied Microbiology and John Wiley & Sons Ltd.
– notice: Attribution - NonCommercial - ShareAlike
DBID 24P
AAYXX
CITATION
7QH
7QL
7ST
7T7
7TN
7U9
7UA
8FD
C1K
F1W
FR3
H94
H95
H97
L.G
M7N
P64
SOI
7X8
7S9
L.6
1XC
VOOES
5PM
DOI 10.1111/1462-2920.16151
DatabaseName Wiley Online Library Open Access (Activated by CARLI)
CrossRef
Aqualine
Bacteriology Abstracts (Microbiology B)
Environment Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
Oceanic Abstracts
Virology and AIDS Abstracts
Water Resources Abstracts
Technology Research Database
Environmental Sciences and Pollution Management
ASFA: Aquatic Sciences and Fisheries Abstracts
Engineering Research Database
AIDS and Cancer Research Abstracts
Aquatic Science & Fisheries Abstracts (ASFA) 1: Biological Sciences & Living Resources
Aquatic Science & Fisheries Abstracts (ASFA) 3: Aquatic Pollution & Environmental Quality
Aquatic Science & Fisheries Abstracts (ASFA) Professional
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biotechnology and BioEngineering Abstracts
Environment Abstracts
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
Hyper Article en Ligne (HAL)
Hyper Article en Ligne (HAL) (Open Access)
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
Aquatic Science & Fisheries Abstracts (ASFA) Professional
Virology and AIDS Abstracts
Technology Research Database
Aqualine
Aquatic Science & Fisheries Abstracts (ASFA) 3: Aquatic Pollution & Environmental Quality
Water Resources Abstracts
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
Oceanic Abstracts
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
ASFA: Aquatic Sciences and Fisheries Abstracts
AIDS and Cancer Research Abstracts
Engineering Research Database
Aquatic Science & Fisheries Abstracts (ASFA) 1: Biological Sciences & Living Resources
Industrial and Applied Microbiology Abstracts (Microbiology A)
Environment Abstracts
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitleList
AGRICOLA
MEDLINE - Academic
CrossRef


Aquatic Science & Fisheries Abstracts (ASFA) Professional
Database_xml – sequence: 1
  dbid: 24P
  name: Wiley Online Library Open Access (Activated by CARLI)
  url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  sourceTypes: Publisher
DeliveryMethod fulltext_linktorsrc
Discipline Biology
DocumentTitleAlternate SALIVA FOR SARS‐CoV‐2 TESTING IN CHILDREN
EISSN 1462-2920
EndPage 4737
ExternalDocumentID PMC9538513
oai_HAL_pasteur_04097919v1
10_1111_1462_2920_16151
EMI16151
Genre article
GrantInformation_xml – fundername: Assistance Publique ‐ Hôpitaux de Paris
  funderid: Code projet: APHP200467/N° IDRCB: 2020‐A00999
– fundername: Ministry of Health
– fundername: ;
  grantid: Code projet: APHP200467/N° IDRCB: 2020‐A00999
GroupedDBID ---
.3N
.GA
.Y3
05W
0R~
10A
1OC
24P
29G
31~
33P
36B
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52S
52T
52U
52W
52X
53G
5GY
5HH
5LA
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A03
AAESR
AAEVG
AAHBH
AAHHS
AAHQN
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABEML
ABJNI
ABPVW
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACFBH
ACGFO
ACGFS
ACPOU
ACPRK
ACRPL
ACSCC
ACXBN
ACXQS
ACYXJ
ADBBV
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFPM
AFGKR
AFPWT
AFRAH
AFWVQ
AFZJQ
AHBTC
AIAGR
AITYG
AIURR
AIWBW
AJBDE
AJXKR
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ASPBG
ATUGU
AUFTA
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMNLL
BMXJE
BNHUX
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRSTM
DU5
EBS
ECGQY
EJD
ESX
F00
F01
F04
F5P
FEDTE
G-S
G.N
GODZA
H.T
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IHE
IX1
J0M
K48
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRSTM
MSFUL
MSSTM
MXFUL
MXSTM
N04
N05
N9A
NF~
O66
O9-
OBS
OIG
OVD
P2P
P2W
P2X
P4D
Q.N
Q11
QB0
R.K
ROL
RX1
SUPJJ
TEORI
UB1
V8K
W8V
W99
WBKPD
WIH
WIK
WNSPC
WOHZO
WQJ
WRC
WXSBR
WYISQ
XG1
XIH
YUY
ZZTAW
~02
~IA
~KM
~WT
AAYXX
AEYWJ
AGHNM
AGQPQ
AGYGG
CITATION
7QH
7QL
7ST
7T7
7TN
7U9
7UA
8FD
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
C1K
F1W
FR3
H94
H95
H97
L.G
M7N
P64
SOI
7X8
7S9
L.6
1XC
VOOES
5PM
ID FETCH-LOGICAL-c5151-8086d30f33622777f7f7c243f7ce937b4a8c61d2cc4936d9c3f0bd672bba83883
IEDL.DBID DR2
ISSN 1462-2912
1462-2920
IngestDate Thu Aug 21 18:39:27 EDT 2025
Wed Sep 03 07:02:00 EDT 2025
Fri Jul 11 18:25:52 EDT 2025
Fri Jul 11 15:38:28 EDT 2025
Fri Jul 25 12:10:39 EDT 2025
Thu Apr 24 22:48:46 EDT 2025
Tue Jul 01 04:00:50 EDT 2025
Wed Jan 22 16:22:31 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 10
Language English
License Attribution-NonCommercial-NoDerivs
Attribution - NonCommercial - ShareAlike: http://creativecommons.org/licenses/by-nc-sa
This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c5151-8086d30f33622777f7f7c243f7ce937b4a8c61d2cc4936d9c3f0bd672bba83883
Notes Funding information
Brigitte Moltrecht, Sylvie van der Werf, Marianne Leruez‐Ville, and Isabelle Sermet‐Gaudelus are co‐last authors.
Assistance Publique ‐ Hôpitaux de Paris, Grant/Award Number: Code projet: APHP200467/N° IDRCB: 2020‐A00999; Ministry of Health
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
PMCID: PMC9538513
Funding information Assistance Publique ‐ Hôpitaux de Paris, Grant/Award Number: Code projet: APHP200467/N° IDRCB: 2020‐A00999; Ministry of Health
ORCID 0000-0003-3105-221X
0000-0002-1769-549X
0000-0001-5537-9482
0000-0001-8476-8196
OpenAccessLink https://proxy.k.utb.cz/login?url=https://onlinelibrary.wiley.com/doi/abs/10.1111%2F1462-2920.16151
PMID 36065993
PQID 2725530576
PQPubID 1066360
PageCount 13
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_9538513
hal_primary_oai_HAL_pasteur_04097919v1
proquest_miscellaneous_2811970100
proquest_miscellaneous_2710969550
proquest_journals_2725530576
crossref_primary_10_1111_1462_2920_16151
crossref_citationtrail_10_1111_1462_2920_16151
wiley_primary_10_1111_1462_2920_16151_EMI16151
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate October 2022
PublicationDateYYYYMMDD 2022-10-01
PublicationDate_xml – month: 10
  year: 2022
  text: October 2022
PublicationDecade 2020
PublicationPlace Hoboken, USA
PublicationPlace_xml – name: Hoboken, USA
– name: Oxford
PublicationSeriesTitle Thematic Issue on Pathogen and Antimicrobial Resistance Ecology
PublicationTitle Environmental microbiology
PublicationYear 2022
Publisher John Wiley & Sons, Inc
Wiley Subscription Services, Inc
Society for Applied Microbiology and Wiley-Blackwell
Publisher_xml – name: John Wiley & Sons, Inc
– name: Wiley Subscription Services, Inc
– name: Society for Applied Microbiology and Wiley-Blackwell
References 2022; 375
2021; 27
2021; 21
2020; 81
2022; 23
2022; 46
2020; 77
2021; 165
2021; 16
2021; 59
2021; 10
2021; 11
2022
2021
2020; 71
2021; 215
2022; 9
2021; 19
2022; 14
2022; 36
2021; 131
2021; 373
2021; 174
2022; 32
2021; 254
2021; 40
2022; 602
e_1_2_10_23_1
e_1_2_10_24_1
López‐Martínez B. (e_1_2_10_20_1) 2020; 77
e_1_2_10_22_1
Malcangi G. (e_1_2_10_21_1) 2022; 9
e_1_2_10_2_1
e_1_2_10_4_1
e_1_2_10_18_1
e_1_2_10_3_1
e_1_2_10_6_1
e_1_2_10_16_1
e_1_2_10_5_1
e_1_2_10_17_1
e_1_2_10_8_1
e_1_2_10_14_1
e_1_2_10_7_1
e_1_2_10_15_1
e_1_2_10_12_1
e_1_2_10_9_1
e_1_2_10_13_1
e_1_2_10_10_1
e_1_2_10_33_1
e_1_2_10_11_1
e_1_2_10_32_1
e_1_2_10_31_1
e_1_2_10_30_1
Lin J. (e_1_2_10_19_1) 2022
e_1_2_10_29_1
e_1_2_10_27_1
e_1_2_10_28_1
e_1_2_10_25_1
e_1_2_10_26_1
References_xml – volume: 27
  issue: 10
  year: 2021
  article-title: Quantifying the relationship between SARS‐CoV‐2 viral load and infectiousness
  publication-title: eLife
– volume: 23
  start-page: 40
  issue: 1
  year: 2022
  end-page: 49
  article-title: Children develop robust and sustained cross‐reactive spike‐specific immune responses to SARS‐CoV‐2 infection
  publication-title: Nature Immunology
– volume: 59
  start-page: e02686
  issue: 2
  year: 2021
  end-page: e02620
  article-title: Saliva is a promising alternative specimen for the detection of SARS‐CoV‐2 in children and adults
  publication-title: Journal of Clinical Microbiology
– volume: 81
  start-page: e48
  issue: 3
  year: 2020
  end-page: e50
  article-title: Viral dynamics of SARS‐CoV‐2 in saliva from infected patients
  publication-title: Journal of Infection
– volume: 165
  year: 2021
  article-title: Saliva sampling for chasing SARS‐CoV‐2: a game‐changing strategy
  publication-title: Pharmacological Research
– volume: 131
  start-page: 540
  issue: 5
  year: 2021
  end-page: 548
  article-title: Saliva sample for the massive screening of SARS‐CoV‐2 infection: a systematic review
  publication-title: Oral Surgery, Oral Medicine, Oral Pathology Oral Radiology
– volume: 602
  start-page: 321
  issue: 7896
  year: 2022
  end-page: 327
  article-title: Local and systemic responses to SARS‐CoV‐2 infection in children and adults
  publication-title: Nature
– volume: 11
  start-page: 3134
  issue: 1
  year: 2021
  article-title: Saliva is more sensitive than nasopharyngeal or nasal swabs for diagnosis of asymptomatic and mild COVID‐19 infection
  publication-title: Scientific Reports
– volume: 16
  issue: 6
  year: 2021
  article-title: Screening for SARS‐CoV‐2 by RT‐PCR: saliva or nasopharyngeal swab? Rapid review and meta‐analysis
  publication-title: PLoS One
– volume: 40
  start-page: e300
  issue: 8
  year: 2021
  end-page: e304
  article-title: Performance of RT‐PCR on saliva specimens compared with nasopharyngeal swabs for the detection of SARS‐CoV‐2 in children: a prospective comparative clinical trial
  publication-title: The Pediatric Infectious Disease Journal
– volume: 46
  start-page: 528
  issue: 4
  year: 2022
  end-page: 536
  article-title: Oral manifestations of coronavirus disease 2019 (COVID‐19): a comprehensive clinicopathologic and immunohistochemical study
  publication-title: American Journal of Surgical Pathology
– year: 2022
  article-title: Where is omicron? Comparison of SARS‐CoV‐2 RT‐PCR and antigen test sensitivity at commonly sampled anatomic sites over the course of disease
  publication-title: medRxiv [Preprint]
– start-page: 1
  year: 2021
  end-page: 15
  article-title: The diagnostic accuracy of saliva testing for SARS‐CoV‐2: a systematic review and meta‐analysis
  publication-title: Oral Diseases
– volume: 27
  start-page: 1330
  issue: 9
  year: 2021
  end-page: 1335
  article-title: Saliva for molecular detection of SARS‐CoV‐2 in school‐age children
  publication-title: Clinical Microbiology and Infection
– volume: 10
  start-page: 967
  issue: 10
  year: 2021
  end-page: 969
  article-title: Diagnostic yield of saliva for SARS‐CoV‐2 molecular testing in children
  publication-title: Journal of the Pediatric Infectious Diseases Society
– volume: 36
  start-page: 1
  issue: 1
  year: 2022
  end-page: 14
  article-title: COVID‐19 in children
  publication-title: Infectious Disease Clinics of North America
– volume: 254
  start-page: 239
  issue: 3
  year: 2021
  end-page: 243
  article-title: Salivary glands are a target for SARS‐CoV‐2: a source for saliva contamination
  publication-title: Journal of Pathology
– volume: 375
  start-page: 1116
  issue: 6585
  year: 2022
  end-page: 1121
  article-title: The changing epidemiology of SARS‐CoV‐2
  publication-title: Science
– volume: 174
  start-page: 501
  issue: 4
  year: 2021
  end-page: 510
  article-title: The sensitivity and costs of testing for SARS‐CoV‐2 infection with saliva versus nasopharyngeal swabs: a systematic review and meta‐analysis
  publication-title: Annals of Internal Medicine
– volume: 27
  start-page: 1146
  issue: 4
  year: 2021
  end-page: 1150
  article-title: Stability of SARS‐CoV‐2 RNA in nonsupplemented saliva
  publication-title: Emerging Infectious Diseases
– volume: 215
  start-page: 273
  issue: 6
  year: 2021
  end-page: 278
  article-title: Adding saliva testing to oropharyngeal and deep nasal swab testing increases PCR detection of SARS‐CoV‐2 in primary care and children
  publication-title: Medical Journal of Australia
– volume: 373
  issue: 6551
  year: 2021
  article-title: Estimating infectiousness throughout SARS‐CoV‐2 infection course
  publication-title: Science
– volume: 21
  issue: 9
  year: 2021
  article-title: One‐year update on salivary diagnostic of COVID‐19
  publication-title: Frontiers in Public Health
– volume: 21
  start-page: 1233
  issue: 9
  year: 2021
  end-page: 1245
  article-title: Diagnostic performance of different sampling approaches for SARS‐CoV‐2 RT‐PCR testing: a systematic review and meta‐analysis
  publication-title: The Lancet Infectious Diseases
– volume: 9
  start-page: 249
  issue: 2
  year: 2022
  article-title: COVID‐19 infection in children and infants: current status on therapies and vaccines
  publication-title: Children (Basel).
– volume: 59
  start-page: e02881
  issue: 5
  year: 2021
  end-page: e02820
  article-title: Performance of saliva, oropharyngeal swabs, and nasal swabs for SARS‐CoV‐2 molecular detection: a systematic review and meta‐analysis
  publication-title: Journal of Clinical Microbiology
– volume: 19
  start-page: 141
  issue: 3
  year: 2021
  end-page: 154
  article-title: Characteristics of SARS‐CoV‐2 and COVID‐19
  publication-title: Nature Reviews Microbiology
– volume: 32
  start-page: 123
  issue: 1
  year: 2022
  end-page: 125
  article-title: Saliva as a reliable sample for COVID‐19 diagnosis in paediatric patients
  publication-title: International Journal of Paediatric Dentistry
– volume: 77
  start-page: 228
  issue: 5
  year: 2020
  end-page: 233
  article-title: Saliva as a promising biofluid for SARS‐CoV‐2 detection during the early stages of infection
  publication-title: Boletín Médico del Hospital Infantil de México
– volume: 71
  start-page: 841
  issue: 15
  year: 2020
  end-page: 843
  article-title: Consistent detection of 2019 novel coronavirus in saliva
  publication-title: Clinical Infectious Diseases
– volume: 59
  start-page: e02881
  issue: 5
  year: 2021
  end-page: e02820
  article-title: Performance of saliva, oropharyngeal swabs, and nasal swabs for SARS‐CoV‐2 molecular detection: a systematic review and meta‐analysis
  publication-title: Clinical Microbiology
– volume: 14
  start-page: 313
  issue: 2
  year: 2022
  article-title: A community study of SARS‐CoV‐2 detection by RT‐PCR in saliva: a reliable and effective method
  publication-title: Viruses
– start-page: 2022.02.08.2227
  year: 2022
  ident: e_1_2_10_19_1
  article-title: Where is omicron? Comparison of SARS‐CoV‐2 RT‐PCR and antigen test sensitivity at commonly sampled anatomic sites over the course of disease
  publication-title: medRxiv [Preprint]
– ident: e_1_2_10_11_1
  doi: 10.1097/INF.0000000000003198
– ident: e_1_2_10_25_1
  doi: 10.3201/eid2704.204199
– ident: e_1_2_10_17_1
  doi: 10.1128/JCM.02881-20
– ident: e_1_2_10_26_1
  doi: 10.1097/PAS.0000000000001825
– ident: e_1_2_10_28_1
  doi: 10.1093/cid/ciaa149
– ident: e_1_2_10_31_1
  doi: 10.1038/s41586-021-04345-x
– ident: e_1_2_10_16_1
  doi: 10.1126/science.abm4915
– ident: e_1_2_10_3_1
  doi: 10.1111/odi.13934
– ident: e_1_2_10_15_1
  doi: 10.1126/science.abi5273
– ident: e_1_2_10_32_1
  doi: 10.1016/j.idc.2021.11.002
– ident: e_1_2_10_2_1
  doi: 10.1016/j.cmi.2021.02.009
– ident: e_1_2_10_24_1
  doi: 10.5694/mja2.51188
– ident: e_1_2_10_5_1
  doi: 10.7326/M20-6569
– ident: e_1_2_10_29_1
  doi: 10.1016/S1473-3099(21)00146-8
– ident: e_1_2_10_14_1
  doi: 10.1371/journal.pone.0253007
– ident: e_1_2_10_23_1
  doi: 10.1002/path.5679
– ident: e_1_2_10_12_1
  doi: 10.3390/v14020313
– ident: e_1_2_10_6_1
  doi: 10.1016/j.phrs.2020.105380
– ident: e_1_2_10_7_1
  doi: 10.3389/fpubh.2021.589564
– ident: e_1_2_10_9_1
  doi: 10.1038/s41590-021-01089-8
– ident: e_1_2_10_13_1
  doi: 10.1038/s41579-020-00459-7
– volume: 77
  start-page: 228
  issue: 5
  year: 2020
  ident: e_1_2_10_20_1
  article-title: Saliva as a promising biofluid for SARS‐CoV‐2 detection during the early stages of infection
  publication-title: Boletín Médico del Hospital Infantil de México
  doi: 10.24875/BMHIM.20000204
– ident: e_1_2_10_8_1
  doi: 10.1016/j.oooo.2021.01.028
– ident: e_1_2_10_10_1
  doi: 10.1111/ipd.12885
– ident: e_1_2_10_27_1
  doi: 10.1038/s41598-021-82787-z
– ident: e_1_2_10_30_1
  doi: 10.1128/JCM.02686-20
– ident: e_1_2_10_18_1
  doi: 10.1128/JCM.02881-20
– volume: 9
  start-page: 249
  issue: 2
  year: 2022
  ident: e_1_2_10_21_1
  article-title: COVID‐19 infection in children and infants: current status on therapies and vaccines
  publication-title: Children (Basel).
– ident: e_1_2_10_33_1
  doi: 10.1016/j.jinf.2020.06.059
– ident: e_1_2_10_4_1
  doi: 10.1093/jpids/piab058
– ident: e_1_2_10_22_1
  doi: 10.7554/eLife.69302
SSID ssj0017370
Score 2.4064806
Snippet SARS‐CoV‐2 diagnosis is a cornerstone for the management of coronavirus disease 2019 (COVID‐19). Numerous studies have assessed saliva performance over...
SARS-CoV-2 diagnosis is a cornerstone for the management of coronavirus disease 2019 (COVID-19). Numerous studies have assessed saliva performance over...
SourceID pubmedcentral
hal
proquest
crossref
wiley
SourceType Open Access Repository
Aggregation Database
Enrichment Source
Index Database
Publisher
StartPage 4725
SubjectTerms Adolescents
Adults
Age
Children
Coronaviruses
COVID-19
COVID-19 infection
Detection
Diagnosis
Life Sciences
microbiology
Nucleotide sequence
patients
Research Paper
Research Papers
Saliva
Sensitivity
Severe acute respiratory syndrome
Severe acute respiratory syndrome coronavirus 2
Signs and symptoms
Symptoms
Viral diseases
Title Saliva for molecular detection of SARS‐CoV‐2 in pre‐school and school‐age children
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2F1462-2920.16151
https://www.proquest.com/docview/2725530576
https://www.proquest.com/docview/2710969550
https://www.proquest.com/docview/2811970100
https://pasteur.hal.science/pasteur-04097919
https://pubmed.ncbi.nlm.nih.gov/PMC9538513
Volume 24
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1ba9swFBZrYNCXdZeOZu2KBmPsxcG6WLIfQ1gJYxujWUfpi5BlmZZtTsil0D3tJ-w37pfsHPlCEmhHGQYjrCOTI58jfYqOvkPI69jGXsPCI9KADSLpUhZZKV0Ux07HylrlNZ53_vhJjc_k-_OkjSbEszA1P0T3hxt6Rhiv0cFtvlhzcnBxHmGupQGCFlwAYcQWwqLTjkCKaRHSxTWyjDfkPhjLs9V-Y17aucSoyDXIuR0wuQ5kw0x0skfyVoc6AOXbYLXMB-7nFr3jfyn5mDxqcCod1ob1hDzw1VPysM5cefOMXEws7iFRgLz0R5thlxZ-GSK7Kjot6WR4Ovnz6_do-hXunF5VdDb3UFwE3k9qq4LWRXgGgxptj5Xvk7OTd19G46hJ0xA5AEMM5rhUFSIuBcyFXGtdwuW4FHD3AH5yaVOnWMGdk5lQReZEGeeF0jzPbSrSVDwnvWpa-QNCC5WUVgPmgvdJ5EJNwgqKWcehQrE-GbQfybiGwxxTaXw37VoGO8xgh5nQYX3ytmswq-k7bhd9A1-9k0La7fHwg5lZ8LbV3MRIDJax7BoEj1rDMI3DLwwHg09g7NSqT1511eCquP9iKz9doQxopDLQ6A6ZFPd1YZEMMnrD6DZ-2WZNdXUZiMEzmL0SJqCXgk39S2MDnh4KL-7b4JDscjwGEoIaj0hvOV_5lwDOlvkx2eHy83Hwwr8DFi8Y
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1fb9MwELdgCMEL499EYQMjIcRLqsRJ7eSxmjYV6PawbmjixXIcR5uAtOpaJHjiI_AZ-ST7nfNHbSVACEWKrPgS5Zw73118_h1jr0ITOoXAI1DwDYLEplFgksQGYWhVKI2RTtF-56NjOTpL3p0Pzlf2wtT4EN0PN9IMP1-TgtMP6RUth46LgIot9clrQQR0i-p6-7DqpIOQilTsC8Y1xJFo4H0om2fjAWuW6eYF5UWuOJ2bKZOrrqy3RYfbzLZc1Ckon_rLRd633zcAHv-PzfvsXuOq8mEtWw_YDVc9ZLfr4pXfHrGPE0PLSBxeL__SFtnlhVv45K6KT0s-GZ5Mfv34uT_9gLPglxWfzR2aVx76k5uq4HUT1zCv8XZn-WN2dnhwuj8KmkoNgYU_FMHMpbKIwzKGORRKqRKHFUmMs4P_kycmtTIqhLVJFssis3EZ5oVUIs9NGqdpvMO2qmnlnjBeyEFpFNwuPC8hONSBD6IiYwU6ZNRj_fYradvAmFM1jc-6DWdowDQNmPYD1mNvuhtmNYLH70lf47N3VIS8PRqO9cxA4ZZzHRI2WBZlX0G420qGbnT-SgvI_ADTp5I99rLrhrbSEoyp3HRJNOBIZuDoDzQpLe0iTgaNWpO6tTdb76kuLzw2eAYDBiXAKHmh-hvHGsruG0__9YYX7M7o9Gisx2-P3z9jdwXtCvE5jrtsazFfuj34aov8uVfGa8D4Mlw
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1tixMxEA56ovjF98PqqRFE_LIlb5vsfix3lqrnIVdPxC8hm81yh7otvVbQT_4Ef6O_xJnsC21BRaSwhGZ2abIzmWeayTOEPGGOBQOBR2IAGyTKZzxxSvmEMW-Ydk4Hg-edXx_pyYl6-T7tsgnxLEzDD9H_4YaWEddrNPB5Wa0ZOZi4SLDW0hBBCwRAl5RmGSr2wXHPIMWNjPXiWmEuWnYfTObZesCGY7p4immRa5hzO2NyHclGVzS-TopuEE0GysfhalkM_bctfsf_GuUNcq0FqnTUaNZNciHUt8jlpnTl19vkw9ThJhIFzEs_dyV2aRmWMbWrprOKTkfH05_ff-zP3sFV0LOazhcBmueR-JO6uqRNE76DVY1258rvkJPx87f7k6St05B4QEMcnFymS8kqCc5QGGMq-HihJFwDoJ9CucxrXgrvVS51mXtZsaLURhSFy2SWyV2yU8_qcJfQUqeVMwC64HkKyVDTGEJx5wV0aD4gw-4lWd-SmGMtjU-2C2ZwwixOmI0TNiDP-hvmDX_H70WfwlvvpZB3ezI6tHMH5rZaWIbMYDnPv4DgXqcYtrX4cytA41NYPI0ekMd9N9gqbsC4OsxWKAMj0jmM6A8yGW7sQpQMMmZD6TZ-2WZPfXYamcFzcF8plzBLUaf-NmILph4b9_71hkfkypuDsT18cfTqPrkq8EhITHDcIzvLxSo8AKC2LB5GU_wFF6MxFA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Saliva+for+molecular+detection+of+SARS%E2%80%90CoV%E2%80%902+in+pre%E2%80%90school+and+school%E2%80%90age+children&rft.jtitle=Environmental+microbiology&rft.au=Agnes+Delaunay%E2%80%90Moisan&rft.au=Guilleminot%2C+Tiffany&rft.au=Semeraro%2C+Michaela&rft.au=Briand%2C+Nelly&rft.date=2022-10-01&rft.pub=Wiley+Subscription+Services%2C+Inc&rft.issn=1462-2912&rft.eissn=1462-2920&rft.volume=24&rft.issue=10&rft.spage=4725&rft.epage=4737&rft_id=info:doi/10.1111%2F1462-2920.16151&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1462-2912&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1462-2912&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1462-2912&client=summon